Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Equity Ratio: 2022-2023

Historic Equity Ratio for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to 0.77.

  • Therapeutics' Equity Ratio fell 18.91% to 0.77 in Q3 2023 from the same period last year, while for Sep 2023 it was 0.77, marking a year-over-year decrease of 18.91%. This contributed to the annual value of 0.92 for FY2022, which is N/A change from last year.
  • Therapeutics' Equity Ratio amounted to 0.77 in Q3 2023, which was down 1.86% from 0.78 recorded in Q2 2023.
  • Therapeutics' Equity Ratio's 5-year high stood at 0.96 during Q2 2022, with a 5-year trough of 0.77 in Q3 2023.
  • In the last 2 years, Therapeutics' Equity Ratio had a median value of 0.92 in 2022 and averaged 0.89.
  • Data for Therapeutics' Equity Ratio shows a maximum YoY decreased of 18.91% (in 2023) over the last 5 years.
  • Therapeutics' Equity Ratio (Quarterly) stood at 0.92 in 2022, then fell by 18.91% to 0.77 in 2023.
  • Its last three reported values are 0.77 in Q3 2023, 0.78 for Q2 2023, and 0.89 during Q1 2023.